Structure of the prothrombin- and blood clotting factor X-membrane complexes

Biochemistry ◽  
1977 ◽  
Vol 16 (19) ◽  
pp. 4177-4181 ◽  
Author(s):  
T. K. Lim ◽  
Victor A. Bloomfield ◽  
Gary L. Nelsestuen
Keyword(s):  
Blood Clotting ◽  
Clotting Factor ◽  
Factor X ◽  
Blood Clotting Factor

scholarly journals An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo.

1990 ◽  
Vol 9 (12) ◽  
pp. 4189-4195 ◽  
Author(s):  
B. Gotoh ◽  
T. Ogasawara ◽  
T. Toyoda ◽  
N. M. Inocencio ◽  
M. Hamaguchi ◽  
...  
Keyword(s):  
Chick Embryo ◽  
Blood Clotting ◽  
Clotting Factor ◽  
Factor X ◽  
Viral Tropism ◽  
Blood Clotting Factor

Simple and rapid method to determine the binding of blood clotting factor X to phospholipid vesicles

Biochemistry ◽  
1981 ◽  
Vol 20 (25) ◽  
pp. 7096-7101 ◽  
Author(s):  
Gerbrand Van Dieijen ◽  
Guido Tans ◽  
Jan Van Rijn ◽  
Robert F. A. Zwaal ◽  
Jan Rosing
Keyword(s):  
Rapid Method ◽  
Blood Clotting ◽  
Clotting Factor ◽  
Phospholipid Vesicles ◽  
Factor X ◽  
Blood Clotting Factor

A case of rare inhibitory coagulopathy - acquired hemophilia A

2010 ◽  
Vol 94 (10) ◽  
pp. 775-779
Author(s):  
V. I. Ershov ◽  
Dar’ya A. Budanova ◽  
I. Yu. Gadaev ◽  
O. V. Bochkarnikova ◽  
I. Ya. Sokolova ◽  
...  
Keyword(s):  
Rare Disease ◽  
Blood Clotting ◽  
Hemophilia A ◽  
Coagulation System ◽  
Clotting Factor ◽  
Factor X ◽  
Acquired Hemophilia A ◽  
Acquired Hemophilia ◽  
Hemostatic Therapy ◽  
Blood Clotting Factor

Inhibitory coagulopathy is a rare variant of hemorrhagic syndrome. Acquired hemophilia A is caused by the formation of inhibitors (antibodies) to Factor VIII of the blood coagulation system leading to impaired activation of the key stage of blood clotting (factor X) and development of hemorrhagic syndrome of different severity. Acquired hemophilia A is a rare disease with an incidence of 1.38-1.48 per 1 million population per year. We report a case off severe idiopathic acquired hemophilia A in a 53 year-old woman manifest as skin hemorrhages, subcutaneous and intramuscular hematomas. Hemostatic therapy described in the article resulted in the elimination of hemorrhagic syndrome and complete remission. This case represents a rare disease the knowledge of which can be useful for preventing the development of debilitating complications, and sometimes saving the patient’s life.

Interaction of prothrombin and blood-clotting factor X with membranes of varying composition

Biochemistry ◽  
1977 ◽  
Vol 16 (19) ◽  
pp. 4172-4177 ◽  
Author(s):  
Gary L. Nelsestuen ◽  
Margaret Broderius
Keyword(s):  
Blood Clotting ◽  
Clotting Factor ◽  
Factor X ◽  
Blood Clotting Factor

The effect of some common environmental factors on the level of blood clotting factor X

1978 ◽  
Vol 12 (1) ◽  
pp. 187-190 ◽  
Author(s):  
R.M. Siervogel ◽  
R.H. Lester ◽  
R.C. Elston ◽  
J.B. Graham
Keyword(s):  
Environmental Factors ◽  
Blood Clotting ◽  
Clotting Factor ◽  
Factor X ◽  
Blood Clotting Factor
Sign in / Sign up

Export Citation Format

Share Document